[Relation between pyloric dysmotility and serum levels of gastrin, somatostatin and vasoactive intestinal polypeptide in patients with non-insulin dependent diabetes mellitus].
Serum levels of gastrin, somatostatin and vasoactive intestinal polypeptide were evaluated in 105 noninsulin dependent diabetics (25 of them had a pyloric dysfunction). The serum levels were determined by RIA and blood was taken before and after the test meal. The basal gastrin level was significantly higher in patients with the pyloric dysfunction (p < 0.001). 45 minutes later the serum levels of vasoactive intestinal polypeptide and somatostatin were significantly higher in diabetics with the pyloric dysfunction (p < 0.001). The serum levels of gastrin, somatostatin and vasoactive intestinal polypeptide were impaired in diabetics with the pyloric dysfunction and might be associated with its pathogenesis.
Kostic N
Klinicko-bolnicki centar Dr Dragisa Misovic, Beograd, Klinika za internu medicinu.
Ratković
M
M
Novaković
R
R
Secen
S
S
D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology*; D004435:Eating; D005260:Female; D005746:Gastric Emptying; D005755:Gastrins / Q000097:blood*; D005769:Gastrointestinal Motility; D006801:Humans; D008297:Male; D008875:Middle Aged; D011708:Pylorus / Q000503:physiopathology; D013004:Somatostatin / Q000097:blood*; D014660:Vasoactive Intestinal Peptide / Q000097:blood*
D005755:Gastrins; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin
Odonos pilorusnog dismotiliteta i serumskih vrednosti gastrina, somatostatina i vazoaktivnog intestinalnog polipeptida u bolesnika s insulinnezavinim dijabetes melitusom.